
Pills, promotions and a dose of doubt: Influencers, VC money fuel India's booming supplements market
Live Events
A decade ago, India's health supplements mostly meant vitamin C, iron and B12 tablets purchased at pharmacies after consulting a doctor. Fast forward to 2025, and a whole new market has emerged—gummies to enhance your hair health, powders to boost collagen, liquid for gut, pills for women's perimenopause hormonal imbalance, magnesium tablets for better sleep, testosterone boosters, capsules with calming properties and vegan versions of all these.The supplement wave in the country was sparked by increased health awareness after the Covid-19 pandemic and powered by social media influencer marketing and a rush of venture capital (VC), according to industry executives and experts.These products are being sold directly to consumers on ecommerce websites as well as quick-commerce apps, spawning a fast-growing segment within the health sector. But as gummies and pills become lifestyle staples, the line between wellness and pseudoscience is blurring. Most items are sold over the counter—with no prescription, no pharmacist and often no clarity on whether they actually work.The result? A shelf full of products that look similar, promise big results and raise a critical question—how much of it is science, and how much social media hype?India's nutritional supplement industry, pegged at $47.92 billion in 2024, is projected to expand to $68.43 billion by 2030, at a compound annual growth rate of 8.1%, according to market research firm Research and Markets. The growth story has attracted both founders and venture capitalists. 'Just after the Covid-19 pandemic, the evolution of these nutra products happened with immunity-building items. After seeing good acceptance from the audience and more usage of digital platforms (ecommerce and quick-commerce) to buy such products, brands started experimenting with their offerings,' said Renu Bisht, founder of Commercify360, a Gurgaon-based brand consulting firm.The funding numbers back this up. According to data firm Venture Intelligence, the sector raised more than $500 million between 2020 and May 2025. The latest in the line is Mumbai-based The Good Bug, a gut health startup that raised about $12 million in a round led by Susquehanna Asia Venture Capital, with Fireside Ventures participating.Ankur Khaitan, principal at Fireside Ventures, emphasised the sharpening focus on science and research, along with innovation, in delivery formats. 'As themes like women's health, longevity and bone health evolve, we are looking to double down on startups operating at the intersection of unmet consumer needs and science-led innovation,' he said.Some health professionals are beginning to worry that the focus is shifting from effectiveness to aesthetics. 'The wellness sector is booming in India, which is why a lot of companies are getting a lot of VC funding early on. They use a lot of that funding to basically not work so much on the formulation but more on the marketability of a product,' said Poorvi Bhat Khandige, a Bengaluru-based naturopathic physician and nutritionist.'Health supplement brands are heavily reaching out to influencers because the concept is fairly new in India,' said Commercify 360's Bisht. 'Brands are partnering with health influencers, doctors and fitness trainers for marketing in order to build the audience's trust. Some brands are spending 15–30% of their budget on influencer marketing.'For example, nutrition brand Plix partners with Gen Z creators to reach urban, health-aware users.Ayurvedic label Kapiva, from Kolkata-based Baidyanath, works with regional wellness influencers, while nutrition brand Fast&Up aligns with athletes and fitness content creators. 'We are trying to reach our target audience and continuously build awareness at the right frequency with them,' said Keshav Biyani, founder of gut health-focused brand The Good Bug.Hindustan Unilever-backed Wellbeing Nutrition , a direct-to-consumer nutraceutical player, said 20-25% of its expenses are allocated to marketing.These companies are ramping up their marketing budgets to build awareness by partnering with doctors and clinics.However, the marketing-first approach leads to many consumers buying the products without understanding them, and sometimes overusing them, leaving experts and nutritionists worried.'We've seen almost 200% growth month-on-month where protein is concerned, which is good and bad,' said Avnish Chhabria, founder of Wellbeing Nutrition. 'It's good, because everyone's gotten the sense and understanding of what they need to take. It's bad, because even people who are eating enough protein in a day are now overconsuming it, which could eventually lead to kidney problems.'The lack of guidance regarding the usage of such products poses a real risk. In some cases, certain ingredients require specific lifestyle choices to be safe.For instance, a Jaipur-based consumer used a popular nutrition brand's metabolically lean powder for more than a year before eventually stopping, after realising that some ingredients in the product required lifestyle adjustments. 'The product has EGCG and ALA (epigallocatechin gallate and alpha-lipoic acid are ingredients typically used in weight loss products), both of which can cause issues if you're not active,' the person said on condition of anonymity.Additionally, some products may fall short of their promises. Hair gummies, for example, are marketed with the promise of improving hair health and making it stronger and shinier. However, according to Khandige, a nutritionist, many of these products don't contain a sufficient therapeutic dose to be truly effective.Even as the market expands, several leading brands are grappling with challenges tied to regulatory scrutiny, supply chain issues and shifting consumer expectations. GNC , a supplement retailer in the US—where the supplements market is projected to exceed $70 billion by 2031, from around $43 billion in 2022, according to data and business intelligence platform Statista—has faced multiple legal battles over product quality. Elysium Health, known for its anti-aging supplements, has drawn criticism from scientists, who have questioned the efficacy of its claims. However, the risk of such products reaching Indian consumers is heightened by the rise of fast and frictionless delivery channels such as quick-commerce apps.Most supplement products in India fall under the purview of the Food Safety and Standards Authority of India, and not the drug regulator. That means weaker scrutiny and lighter penalties despite brands making bold claims like 'improves liver health' or 'reverses aging'.Health experts have long called for stringent oversight. Recently, an inter-ministerial committee headed by former health secretary Apurva Chandra recommended that any supplement claiming to treat or mitigate a disease should be classified as a drug. That would bring such products under the Central Drugs Standard Control Organisation and subject them to stricter regulation. Experts agree that until there is better education, regulation and transparency, consumers will largely have to navigate this booming market on their own—one Instagram ad at a time.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
18 minutes ago
- Time of India
108 Covid cases reported in 24 hrs, 461 active in Gujarat
Ahmedabad/Surat: In the 24 hours ending at 5 pm on Tuesday, the state reported 108 new Covid cases, taking the total number of active cases to 461, according to a bulletin issued by the state health department. The data indicated that out of the total active cases, 20 were hospitalised, while the remaining 441 were in home isolation. In the same period, 43 patients were discharged, and one patient succumbed to the infection, as per the bulletin. An analysis of the Covid case details from Ahmedabad city indicated that about 10-15% of the total cases are below five years of age. At least five patients were below one year in major hospitals, according to the data. "Moreover, the majority of the patients are recorded in the below 60 years or working population this wave. In comparison, the earlier waves had patients in senior citizen age categories," said a health department official. Two deaths recorded in the city were also reported in relatively younger ages — 18 and 47 years. Both were women and had comorbidities, added officials. However, a more detailed analysis of the cases may point to possible reasons for the deaths, said officials. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Mistura chinesa faz cabelo crescer e homem fica irreconhecível Resultados em 30 dias Undo "Across India, five deaths have been reported in the past 24 hours, and the reasons, as mentioned by the MoHFW website, point towards respiratory illnesses along with diabetes, hypertension, heart, and kidney diseases. The deaths recorded on the website have only one person below 50 years. Thus, the trend in Gujarat is slightly different from the one observed across India," said a city-based physician, adding that there is no need for concern, but for caution. "If the flu-like symptoms persist for more than two days, medical help should be availed." Three more persons were diagnosed with Covid in Surat Municipal Corporation (SMC) limits, which include two women aged 64 and 19 years, while the third was a 38-year-old man. The first case pertains to a 64-year-old woman from the Adajan area of Surat, who is a homemaker. She returned from Dehradun on May 29 and is currently stable in home isolation. She has a history of high blood pressure. The second case is related to a 19-year-old woman, residing in Sachin, who is a nursing student. She is currently in home isolation, and her condition is stable. A 38-year-old man, residing in Umra village, who works as a labourer, was also diagnosed with Covid infection. He is also in home isolation. Samples from these patients have been sent to GBRC, Gandhinagar, for genome sequencing as per govt guidelines. Covid positive patients in home isolation have been advised to remain isolated for five days.


Time of India
an hour ago
- Time of India
Overlapping symptoms make Cov diagnosis difficult without tests
Kolkata: The overriding symptoms of Covid during the current surge were a low-grade, persistent fever, along with a mild cough, which could be deceptive, warned doctors. While it made a vast majority ignore the symptoms and take over-the-counter medicines, for some, the fever refused to subside. It was the continuing fever that led many to consult physicians. Most of those testing Covid positive on admission to hospitals for other ailments were also screened at hospitals due to their fever. Covid cases have been rising in Bengal over the past week. The state logged 319 cases in the past seven days, taking the number of active cases to 331 on Monday. Unlike the first three waves, when Covid came with loss of smell and taste, accompanied by high fever, severe cough and pneumonia, the symptoms of the current spike were muted and flu-like, said doctors. With a runny nose and a sore throat, symptoms in most were milder than that during the pandemic, said CMRI pulmonology director Raja Dhar. "Mild symptoms led many to ignore it, which could be risky at a time, when cases are proliferating. One should get tested, and if the result turns positive, the patient should isolate, especially if there are elders in the family. Screening should be stricter for elderly people with comorbidities, and if the fever and cough persist beyond four to five days, hospitalization is advised as symptoms could worsen quickly," said Dhar. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Beyond Text Generation: An AI Tool That Helps You Write Better Grammarly Install Now Undo CMRI has seven Covid patients admitted. Manipal Hospitals infectious diseases physician Sayan Chakrabarty agreed. "The symptoms are flu-like, but for some, the fever persists. Those patients are getting tested, and many tested positive. While severe cases have been rare so far, rising numbers could lead to a spurt," he added. Five Covid patients, admitted to Manipal's different units, have been discharged. Covid pneumonia has been rare this time, said Charnock Hospital pulmonologist Soumya Sengupta. "Most patients have a cough and low fever. Even the elders in hospital who tested positive have muted Covid symptoms. Most are being treated for their comorbidities. During the pandemic, a vast majority of senior citizens had severe Covid symptoms, including pneumonia," said Sengupta. Dhar pointed out that the Jn.1 variant of the Omicron, now believed to be in circulation, was highly transmissible though less virulent. "But it is safe to isolate yourself for five days on testing positive and take symptomatic drugs. Symptoms are likely to remain mild till this wave blows over in about a fortnight. But even mild Covid may aggravate comorbidities, especially those related to lungs," he said.


Time of India
an hour ago
- Time of India
New Covid vaccine developed by USA researchers is ready to fight Coronavirus. How effective it is?
Amid fresh surge in Covid-19 cases, a team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously evolving viruses such as SARS-CoV-2 and H5N1. While the currently available mRNA vaccines are highly effective at inducing an immune response against Covid , they present challenges like the high amount of mRNA needed to produce them and the constantly evolving nature of the pathogen. "The virus changes, moving the goal post, and updating the vaccine takes some time," said senior author Suresh Kuchipudi, chair of Infectious Diseases and Microbiology at the University of Pittsburgh School of Public Health. To address these challenges, the researchers created a proof-of-concept Covid vaccine using what's known as a "trans-amplifying" mRNA platform. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Pare a neuropatia: descubra como NeuroFit Undo In this approach, the mRNA is separated into two fragments -- the antigen sequence and the replicase sequence -- the latter of which can be produced in advance, saving crucial time in the event a new vaccine must be developed urgently and produced at scale. In addition, the researchers analysed the spike-protein sequences of all known variants of the SARS-CoV-2 for commonalities, rendering what's known as a "consensus spike protein" as the basis for the vaccine's antigen. Live Events In mice, the vaccine induced a robust immune response against many strains of SARS-CoV-2. "This has the potential for more lasting immunity that would not require updating, because the vaccine has the potential to provide broad protection," said Kuchipudi. "Additionally, this format requires an mRNA dose 40 times less than conventional vaccines, so this new approach significantly reduces the overall cost of the vaccine." The study, published in the journal npj Vaccines could inform more efficient vaccine development for other constantly evolving RNA viruses with pandemic potential, Kuchipudi said.